Malignant hyperthermia: An inherited disorder of skeletal muscle Ca2+ regulation

Bioscience Reports

Volumn 21, Issue 2, 2001, Pages 155-168

  Louis, C F ^a   Balog, E M ^a   Fruen, B R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Ca2+; Excitation contraction coupling; Malignant hyperthermia; Ryanodine receptor; Skeletal muscle

Indexed keywords

ANESTHETIC AGENT; CALCIUM CHANNEL; CALCIUM ION; CALMODULIN; DANTROLENE; HALIDE; MEMBRANE PROTEIN; MUSCLE RELAXANT AGENT; NEUROMUSCULAR DEPOLARIZING AGENT; RYANODINE RECEPTOR;

CALCIUM TRANSPORT; EXCITATION CONTRACTION COUPLING; GENE LOCUS; GENE MUTATION; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HUMAN; HYPERMETABOLISM; MALIGNANT HYPERTHERMIA; MUSCLE CONTRACTURE; NONHUMAN; PHARMACOGENETICS; REGULATORY MECHANISM; SHORT SURVEY;

ANIMALS; CALCIUM; DANTROLENE; HUMANS; MALIGNANT HYPERTHERMIA; MODELS, BIOLOGICAL; MUSCLE RELAXANTS, CENTRAL; MUSCLE, SKELETAL; MUTATION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 0035170454     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013644107519     Document Type: Short Survey

References (69)

1. Charge movement and the nature of signal transduction in skeletal muscle excitation-contraction coupling
2. Calcium ion in skeletal muscle: Its crucial role for muscle function, plasticity, and disease
3. Malignant hyperthermia: Biochemical aspects of the acute episode
4. Aetiology of malignant hyperthermia
5. Malignant hyperthermia: A statistical review
6. Retrospective analysis of anesthetics received by patients before susceptibility to malignant hyperthermia was recognized
7. Ryanodine receptor mutations in malignant hyperthermia and central core disease
8. Unusual reaction to suxamethonium chloride
9. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia
10. The pharmacology of ryanodine
11. 2+ release channel
12. Metabolic error of muscle metabolism after recovery from malignant hyperthermia
13. 2+] during a malignant hyperthermia episode in swine
14. 2+] in human skeletal muscle
15. The caffeine test of isolated human muscle in relation to malignant hyperthermia
16. Standardization of the caffeine halothane muscle contracture test
17. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility
18. Dantrolene - An update
19. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine
20. Molecular cloning of cDNA encoding human and rabbit forms of the calcium release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum
21. Three-dimensional architecture of the calcium channel/foot structure of sarcoplasmic reticulum
22. The ryanodine receptor family of intracellular calcium release channels
23. 2+ release channel
24. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of the FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum
25. 2+ release channel
26. Locations of calmodulin and FK506-binding protein on the three-dimensional architecture of the skeletal muscle ryanodine receptor
27. Voltage dependent charge movement of skeletal muscle: A possible step in excitation-contraction coupling
28. Ryanodine receptors of striated muscles: A complex channel capable of multiple interactions
29. Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA
30. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling
31. 2+ ions in excitation-contraction coupling of skeletal muscle fibers
32. 2+ regulation defects
33. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia
34. Genetics and pathogenesis of malignant hyperthermia
35. 2+ release channels
36. Abnormality in calcium release from skeletal muscle sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia
37. 2+ pump inhibition
38. Mechanical properties of normal and malignant hyperthermia susceptible porcine muscle: Effects of halothane and other drugs
39. Changes in the Ca-induced Ca release mechanism in the sarcoplasmic reticulum of the muscle from a patient with malignant hyperthermia
40. Effects of perchlorate on the molecules of excitation-contraction coupling of skeletal and cardiac muscle
41. 2+ activation of ryanodine receptors
42. Perchlorate action on malignant hyperthermia susceptible muscle
43. Porcine malignant hyperthermia: Genotype and contractile threshold of immature muscles
44. Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of release
45. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermiasusceptible muscle
46. 2+ release channel
47. 2+ release from sarcoplasmic reticulum of normal and malignant hyperthermia susceptible pig muscles
48. Abnormal ryanodine receptor channels in malignant hyperthermia
49. The effects of volatile anesthetics on calcium regulation by malignant hyperthermia-susceptible sarcoplasmic reticulum
50. 2+ release by direct and specific action at skeletal muscle ryanodine receptors
51. Calmodulin sensitivity of the sarcoplasmic reticulum ryanodine receptor from normal and malignant-hyperthermia-susceptible muscle
52. 2+ release channel
53. Dantrolene, a direct acting skeletal muscle relaxant
54. Dantrolene - In vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle
55. 2+ release channels: Molecular mechanism and isoform specificity
56. 2+ and calmodulin
57. 2+ sensitivity of skeletal and cardiac muscle ryanodine receptor isoforms in presence of calmodulin
58. The 160kDa dantrolene binding protein is a nucleotide-dependent N-calpain derived fragment of the ryanodine receptor
59. Control of calcium release in functioning skeletal muscle fibers
60. 2+ release in skeletal muscle cells
61. 2+ gating of skeletal muscle and cardiac ryanodine receptors
62. Sarcoplasmic reticulum release channels from frog skeletal muscle display two types of calcium dependence
63. 2+ release channels: Does diversity in form equal diversity in function?
64. Excitation-contraction coupling in skeletal muscle: Comparisons with cardiac muscle
65. 2+ release in skeletal muscle fibres of the toad
66. 2+ inhibition and malignant hyperthermia
67. 2+ release channels in malignant hyperthermia
68. Reconstitution of abnormalities in the malignant hyperthermia susceptible pig ryanodine receptor
69. Effect of dantrolene sodium on calcium movements in single muscle fibres